Therapeutic possibilities for the correction of cognitive and psychoemotional impairments in patients with post-covid syndrome

Conclusion

1. 
   Analysis of the above confirms that half of the patients have CI, which during the entire period of rehabilitation have instability, at best fixed at the level of mild CI and moderate CI. The most pronounced effect of BAC-therapy affected the stabilization of neuropsychological testing parameters in the cognitive sphere during the rehabilitation period, compared with the parameters in patients receiving standard therapy (p 0.017).
   
2. 
   The level of attention according to the Schulte test, despite the absence of statistically significant differences when comparing categorized data (test performance for 40 seconds and more than 40 seconds), in the group of patients who received BAC therapy, had a significantly more pronounced positive dynamics than in the group of patients who were on standard treatment. This is confirmed by the result of comparing quantitative data. It follows that a decrease in attention, exhaustion during the test was noted in both groups in most patients. The identified neuropsychological signs of the disease, which were expressed in a decrease in attention, inertia, and a decrease in memorization observed at the beginning of the study, tend to fluctuate, which indicates a disruption in the functioning of brain neurons in conditions of ischemia against the background of lung tissue damage. However, in the main group, a slight improvement in concentration, reaction speed, and a decrease in fatigue during the test were recorded compared to the control group. The results achieved in the cognitive sphere were more stable and persisted throughout the course of BAC therapy. Restoration of impaired functions, reduction of the consequences of ischemic damage indicate the effectiveness of the ongoing BAC therapy.
   

References

1. 
   Vasilevsky N.N. and others / In the book. Biofeedback-2: theory and practice. - Novosibirsk, 1993.– P.65–75.
   
2. 
   Ternovykh I.K., Topuzova M.P., Chaikovskaya A.D. Neurological manifestations and complications in patients with COVID-19. translational medicine. 2020; 7(3): 21-29. DOI: 10.18705/2311-4495-2020-7-3-21-29.
   
3. 
   Shchegolkov A.M., Belyakin S.A., Yaroshenko V.P. et al. Application of bioacoustic psychocorrection technique in complex rehabilitation of hypertensive patients//Physiotherapy, balneology and rehabilitation.– 2007.-№1.- P. 11-15.
   
4. 
   Jeong H., Yim H.W., Song Y.J. et al. Mental health status of people isolated due to Middle East Respiratory Syndrome. Epidemiol Health. 2016:38. DOI:10.4178/epih.e2016048.
   
5. 
   Kim J.E., Heo J.H., Kim H.O. et al. Neurological complications during treatment of middle east respiratory syndrome. J. Clin. Neurol. 2017;13:227–233. 10.3988/jcn.2017.13.3.227
   
6. 
   Lane T.E., Hosking M.P. The pathogenesis of murine coronavirus infection of the central nervous system. Crit. Rev. Immunol. 2010;30:119–130. 10.1615/critrevimmunol.v30.i2.20
   
7. 
   Li Y., Li H., Fan R. et al. Coronavirus infections in the Central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2017;59:163-169. 10.1159/000453066
   
8. 
   Manjunatha N., Math S.B., Kulkarni G.B., Chaturvedi S.K. The neuropsychiatric aspects of influenza/swine flu: A selective review. Ind. Psychiatry J. 2011;20:83–90. 10.4103/0972-6748.102479.
   
9. 
   Mao L., Wang M., Chen S. et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020. 10.1101/2020.02.22.20026500
   
10. 
    Zhao J., Sun L., Li X. Commanding CNS Invasion: GM-CSF. Immunity. 2017;46:165–167. 10.1016/j.immuni.2017.02.003